UY30007A1 - USE OF PALIPERIDONE FOR THE TREATMENT OF A MENTAL DISORDER IN A PSYCHIATRIC PATIENT WITH REDUCED HEPATIC OPERATION - Google Patents

USE OF PALIPERIDONE FOR THE TREATMENT OF A MENTAL DISORDER IN A PSYCHIATRIC PATIENT WITH REDUCED HEPATIC OPERATION

Info

Publication number
UY30007A1
UY30007A1 UY30007A UY30007A UY30007A1 UY 30007 A1 UY30007 A1 UY 30007A1 UY 30007 A UY30007 A UY 30007A UY 30007 A UY30007 A UY 30007A UY 30007 A1 UY30007 A1 UY 30007A1
Authority
UY
Uruguay
Prior art keywords
paliperidone
treatment
mental disorder
reduced hepatic
psychiatric patient
Prior art date
Application number
UY30007A
Other languages
Spanish (es)
Inventor
Sandra Boom
Marie-Henriette
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/534,623 external-priority patent/US20070197591A1/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of UY30007A1 publication Critical patent/UY30007A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona un método para el tratamiento de pacientes psiquiátricos que padecen o tienen riego de deterioro hepático, que comprende administrar una cantidad terapéuticamente efectiva de paliperidona, sus sales de adición con ácidos, formas enantioméricas y ésteres de la misma aceptables para su uso farmacéutico a pacientes psiquiátricos que lo necesitan.The present invention provides a method for the treatment of psychiatric patients suffering from or having a risk of hepatic impairment, which comprises administering a therapeutically effective amount of paliperidone, its acid addition salts, enantiomeric forms and esters thereof acceptable for pharmaceutical use. to psychiatric patients who need it.

UY30007A 2005-12-12 2006-12-12 USE OF PALIPERIDONE FOR THE TREATMENT OF A MENTAL DISORDER IN A PSYCHIATRIC PATIENT WITH REDUCED HEPATIC OPERATION UY30007A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74951505P 2005-12-12 2005-12-12
US74522906P 2006-04-20 2006-04-20
US11/534,623 US20070197591A1 (en) 2005-12-12 2006-09-22 Use of paliperidone for the treatment of a mental disorder in a psychiatric patient with reduced hepatic function

Publications (1)

Publication Number Publication Date
UY30007A1 true UY30007A1 (en) 2007-03-30

Family

ID=38429089

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30007A UY30007A1 (en) 2005-12-12 2006-12-12 USE OF PALIPERIDONE FOR THE TREATMENT OF A MENTAL DISORDER IN A PSYCHIATRIC PATIENT WITH REDUCED HEPATIC OPERATION

Country Status (4)

Country Link
AR (1) AR058328A1 (en)
PE (1) PE20070749A1 (en)
TW (1) TW200800216A (en)
UY (1) UY30007A1 (en)

Also Published As

Publication number Publication date
PE20070749A1 (en) 2007-08-11
AR058328A1 (en) 2008-01-30
TW200800216A (en) 2008-01-01

Similar Documents

Publication Publication Date Title
AR091876A1 (en) PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
AR050623A1 (en) METHOD FOR THE TREATMENT OF THE ATTENTION DEFICIT HYPERACTIVITY DISORDER
GT200800138A (en) COMBINATION OF AN ACETILCOLINESTERASE INHIBITOR AND A 5-HT6 AGONIST FOR THE COGNITIVE DYSFUNCTION TREATMENT
EA201100621A1 (en) TREATMENT OF DIABETES IN PATIENTS IN WHICH ARE INSUFFICIENT GLYCEMIC CONTROL OBSERVING THEREOF WITH ORAL OR NON-ORAL ANTI-DIABETIC MEDICINE
PA8637301A1 (en) DERIVATIVES OF AMINO-5, 5-DIFENYLIMIDAZOLONE FOR THE INHIBITION OF THE B-SECRETASE
BRPI0618239A8 (en) use of flibanserin for the treatment of premenopausal sexual desire disorders
AR048833A1 (en) PROCEDURE FOR THE TREATMENT OF PREMENSTRUAL DISORDERS AND OTHER FEMALE SEXUAL DISORDERS
CR11510A (en) USE OF A GAMMA-SECRETASE INHIBITOR FOR CANCER TREATMENT
EA200802208A1 (en) APPLICATION OF FLIBANSTERIN FOR THE TREATMENT OF DISEASES OF THE SEXUAL TREATMENT IN THE POST-CLIMACTERNIC PERIOD
DE602006015963D1 (en) IMMUNOSTIMULATIVE PROCEDURE
CO6450649A2 (en) LIQUID FORMULATIONS OF SALTS 1- [2- (2,4-DIMETHYLPHENYL SULFANIL) -PENYL] PIPERAZINE
ECSP099556A (en) NEW METHODS
ATE540690T1 (en) INSULIN COMBINATIONS
RS52867B (en) Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
CL2011002766A1 (en) Carboxamide derived compounds, calpain inhibitors; pharmaceutical composition comprising them; and its use in the treatment of neurodegenerative diseases, alzahimer, pain, among others.
EA201270071A1 (en) A METHOD OF TREATING A PATIENT NEEDING ASPIRIN TREATMENT
MX2009004017A (en) The uses of the carboxy-amido-triazole compounds and salts thereof.
AR087744A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
BRPI0817275A2 (en) Pharmaceutical combination of aliskiren and valsartan
BRPI0703970A2 (en) treatment of psychiatric patients with reduced liver function with paliperidone
AR053928A1 (en) REACTIVE METHODS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
CL2011001258A1 (en) Citric acid addition salts of (r) -5 - ((e) -2-pyrrolidin-3-yl vinyl) pyrimidine; polymorphic monoitrate forms; pharmaceutical composition that includes them; and its use in the prevention or treatment of pain, inflammation or a disorder of the central nervous system.
CR9200A (en) USE OF A 5-HT6 AGONIST FOR THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
CL2007000836A1 (en) USE OF COMPOUNDS DERIVED FROM STROBILURINE AND / OR ITS PHYSIOLOGICALLY TOLERATED SALTS TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT AND / OR PREVENTION OF IRON METABOLISM DISORDERS.